Obstructive jaundice

Surgical approach (typical procedures causing/relieving obstruction)

  • Endoscopic biliary decompression
    • Sphincterotomy ± stone extraction, biliary stent insertion
    • May be combined with EUS-guided biopsy/drainage in malignancy
  • Laparoscopic/open biliary surgery
    • Intra-operative cholangiography, transcystic exploration or choledochotomy
    • T-tube occasionally used (less common now)
  • Biliary bypass / drainage for unresectable malignancy
    • Palliative bypass when ERCP/stenting not possible or failed
  • Resection for periampullary/pancreatic head malignancy
    • Resection of pancreatic head/duodenum ± distal stomach, reconstruction with pancreaticojejunostomy, hepaticojejunostomy, gastrojejunostomy
    • Major blood loss/physiological insult, long case

Anaesthetic management (procedure-dependent overview)

  • Type of anaesthesia
    • ERCP: deep sedation or GA depending on aspiration risk, complexity, prone/semi-prone positioning, comorbidity
    • Major surgery (Whipple/bypass): GA + regional/neuraxial adjunct where appropriate
  • Airway
    • ERCP: ETT if high aspiration risk (full stomach, gastric outlet obstruction, sepsis), prolonged/complex, or need for controlled ventilation in prone
    • SGA may be acceptable for short, low-risk ERCP in experienced units, consider access/positioning limitations
  • Duration
    • ERCP: ~30–90 min (can be longer if difficult cannulation/stone work)
    • Cholecystectomy/CBD exploration: ~1–3 h
    • Whipple: ~4–8+ h
  • Pain
    • ERCP: usually mild post-procedure discomfort, watch for pancreatitis
    • Upper abdominal laparotomy (bypass/Whipple): severe, consider epidural or alternative regional techniques + multimodal analgesia
  • Key anaesthetic themes in obstructive jaundice
    • Treat cholangitis aggressively, anticipate vasopressor requirement and postoperative critical care
    • Check coagulation before neuraxial/regional blocks, correct vitamin K deficiency and manage anticoagulants

Definition and causes

  • Obstructive jaundice = conjugated hyperbilirubinaemia due to impaired bile flow (intrahepatic cholestasis or extrahepatic obstruction).
  • Common causes
    • Choledocholithiasis ± cholangitis
    • Pancreatic head cancer, cholangiocarcinoma, ampullary carcinoma
    • Benign strictures (post-surgical), primary sclerosing cholangitis
  • Clinical features
    • Cholangitis: fever, RUQ pain, jaundice (Charcot triad) ± hypotension/confusion (Reynolds pentad)

Pathophysiology relevant to anaesthesia

  • Cardiovascular
    • Endotoxaemia and inflammatory mediators → vasoplegia, may be exaggerated at induction
    • Cirrhosis may coexist (portal HTN, hyperdynamic circulation)
  • Renal
    • Bile salts/endotoxin + hypovolaemia/sepsis → renal vasoconstriction/tubular injury
    • Higher susceptibility to nephrotoxins (NSAIDs, aminoglycosides, contrast) and peri-operative hypotension
  • Coagulation
    • Reduced bile salts in gut → fat malabsorption → reduced vitamin K absorption → ↓ factors II, VII, IX, X (↑ PT/INR)
    • Thrombocytopenia may occur with sepsis, hypersplenism, marrow suppression or malignancy
  • Hepatic drug handling
    • Reduced hepatic uptake/excretion of drugs, hypoalbuminaemia → ↑ free fraction of highly protein-bound drugs
    • Cholestasis can prolong action of some agents, titrate to effect and use depth/neuromuscular monitoring
  • Infection and inflammation
    • Biliary obstruction predisposes to ascending infection, instrumentation (ERCP) can precipitate bacteraemia
    • Sepsis → vasoplegia, myocardial depression, coagulopathy, AKI, encephalopathy
  • Respiratory/GI
    • Delayed gastric emptying (pain, opioids, sepsis) and gastric outlet obstruction in pancreatic malignancy
    • Pruritus and sleep disturbance → fatigue, consider peri-operative delirium risk

Assessment and investigations

  • History/exam
    • Symptoms of cholangitis, pancreatitis, weight loss, pruritus, bleeding/bruising, confusion (encephalopathy/sepsis)
    • Volume status, signs of chronic liver disease, cardiorespiratory reserve (major upper abdominal surgery)
  • Blood tests
    • Cholestatic pattern: ↑ ALP/γGT, ↑ conjugated bilirubin, transaminases variable
    • FBC (anaemia, WCC), U&amp,E/creatinine, glucose, CRP, group &amp, save/crossmatch for major surgery
    • PT/INR, fibrinogen, consider TEG/ROTEM if available for major surgery or bleeding
  • Imaging and staging
    • Ultrasound: duct dilatation, gallstones, CT/MRCP for level/cause, EUS/ERCP for intervention/biopsy

Pre-operative optimisation

  • Treat sepsis early
    • Broad-spectrum antibiotics per local policy, source control via urgent biliary drainage (ERCP/PTC/surgery)
    • Resuscitate: fluids, lactate monitoring, early vasopressors if needed, consider ICU
  • Correct coagulopathy
    • Vitamin K (e.g., 10 mg IV) if INR elevated due to cholestasis, allow time to work if elective
    • If urgent/bleeding: PCC/FFP guided by INR/viscoelastic testing, platelets if indicated
  • Renal protection
    • Optimise volume status, avoid NSAIDs if AKI risk, careful with contrast, dose-adjust renally cleared drugs
  • Nutrition and metabolic issues
    • Consider dietetic input, correct electrolytes, manage diabetes (pancreatic disease)
  • Pre-operative biliary drainage (PBD) in malignancy
    • May be used for cholangitis, severe pruritus, renal dysfunction, very high bilirubin, neoadjuvant therapy, or delay to surgery
    • Can increase infectious complications, decision is MDT- and patient-specific

Intra-operative management (general principles)

  • Monitoring and access
    • Major surgery/sepsis: arterial line before induction if unstable, large-bore IV access, consider CVC for vasoactive infusions and access
    • Temperature, urine output, serial ABG/lactate for major cases
  • Induction and haemodynamics
    • Titrate induction agents, consider reduced doses if septic/vasodilated
    • Have vasopressors ready (metaraminol/phenylephrine, noradrenaline infusion for ongoing vasoplegia)
  • Airway/aspiration precautions
    • Full stomach, obstruction, sepsis, opioids, or ERCP in prone: consider RSI with cuffed ETT
  • Ventilation
    • Upper abdominal surgery: moderate PEEP, avoid high driving pressures, recruitment as needed, consider epidural effects on ventilation
  • Fluids and blood
    • Balance avoiding hypoperfusion (AKI) vs overload, use dynamic indices/CO monitoring if available
    • Crossmatch for major surgery, cell salvage may be considered (institutional policy, malignancy considerations)
  • Analgesia
    • Epidural can provide excellent analgesia for laparotomy but requires acceptable coagulation and haemodynamic tolerance
    • Alternatives: intrathecal opioid, TAP/subcostal TAP, rectus sheath blocks, wound catheters, IV lidocaine (local policy), ketamine
  • Antibiotics
    • Ensure appropriate biliary coverage and redose for long cases/major blood loss

Post-operative care

  • Disposition
    • Sepsis, major resection, significant comorbidity, vasopressor requirement, major blood loss → critical care
  • Complications to anticipate
    • ERCP: pancreatitis, perforation, bleeding, cholangitis, monitor pain, amylase/lipase if symptomatic
    • Whipple: pancreatic fistula, delayed gastric emptying, haemorrhage, intra-abdominal sepsis
  • Analgesia and PONV
    • Upper abdominal surgery: aggressive multimodal analgesia, avoid excessive opioids where possible
    • PONV prophylaxis, consider NG tube per surgical plan (especially gastric outlet issues)

Test yourself…

You are asked to anaesthetise a patient with obstructive jaundice for ERCP. What are your main concerns and how will you plan the anaesthetic?

Structure: patient factors (sepsis/aspiration/coagulation/renal), procedure factors (positioning, access), and a pragmatic plan (sedation vs GA).

  • Concerns
    • Cholangitis → vasoplegia at induction, need for vasopressors, potential ICU
    • Aspiration risk: delayed gastric emptying, opioids, gastric outlet obstruction, prone/semi-prone limits airway access
    • Coagulopathy from vitamin K deficiency, thrombocytopenia in sepsis/malignancy
    • Renal vulnerability, avoid hypotension and nephrotoxins
  • Plan
    • If septic/aspiration risk/complex ERCP: RSI, cuffed ETT, controlled ventilation, arterial line if unstable
    • If low risk/short ERCP: deep sedation may be acceptable with capnography, suction, readiness to convert to GA
    • Antibiotics as indicated, fluids and vasopressors prepared, post-procedure monitoring for pancreatitis/sepsis
Explain why obstructive jaundice is associated with a prolonged PT/INR and how you would manage this peri-operatively.

Aim: link cholestasis to vitamin K malabsorption and reduced synthesis of vitamin K-dependent clotting factors, then give a practical correction strategy.

  • Mechanism
    • Bile salts are required for micelle formation and absorption of fat-soluble vitamins (A, D, E, K)
    • Vitamin K deficiency → reduced γ-carboxylation → ↓ activity of factors II, VII, IX, X (and proteins C/S) → prolonged PT/INR
  • Management
    • Give IV vitamin K (time-dependent effect, best if elective)
    • If urgent surgery or active bleeding: PCC or FFP guided by INR/TEG/ROTEM, correct fibrinogen/platelets as needed
    • Neuraxial techniques only if coagulation acceptable and stable, document trend and timing of correction
A jaundiced patient becomes profoundly hypotensive after induction. What are the likely causes and your immediate management?

Think vasoplegia (sepsis/endotoxin), hypovolaemia, myocardial depression, bleeding, anaphylaxis, and drug effects, treat simultaneously.

  • Likely causes
    • Septic vasodilation/endotoxaemia, exaggerated response to induction agents
    • Relative hypovolaemia from poor intake, third spacing, diuretics
    • Myocardial depression (sepsis/ischaemia) or arrhythmia, less commonly anaphylaxis
  • Immediate management
    • 100% O2, check airway/ventilation, deepen/adjust anaesthesia, confirm rhythm, treat arrhythmias
    • Give vasopressor boluses (e.g., metaraminol/phenylephrine) and start noradrenaline infusion early if persistent
    • Fluid bolus guided by response, consider arterial line, ABG/lactate, search for bleeding/anaphylaxis
Discuss how obstructive jaundice affects the kidneys and how you would reduce peri-operative AKI risk.

FRCA focus: mechanisms + practical anaesthetic measures.

  • Why AKI risk is increased
    • Systemic inflammation/endotoxaemia → renal vasoconstriction and microcirculatory dysfunction
    • Hypovolaemia and vasodilation → reduced renal perfusion pressure
    • Higher susceptibility to nephrotoxins and contrast, sepsis-associated tubular injury
  • Risk reduction
    • Maintain MAP (individualised, often ≥65 mmHg, higher if chronic HTN) with fluids + vasopressors
    • Avoid NSAIDs in high-risk patients, dose-adjust renally cleared drugs, careful with contrast
    • Monitor urine output, creatinine trend, lactate/acid-base, consider goal-directed fluid therapy in major surgery
What are the anaesthetic implications of pruritus and cholestasis-related malnutrition in obstructive jaundice?

Often overlooked: functional status, skin integrity, drug binding, and peri-operative delirium risk.

  • Pruritus
    • Fatigue and reduced physiological reserve, consider delirium risk in older/septic patients
    • Skin damage may affect monitoring/IV access, infection risk if excoriated
  • Malnutrition/hypoalbuminaemia
    • Reduced protein binding → increased free fraction of some drugs, titrate opioids/sedatives carefully
    • Impaired immunity and wound healing, higher postoperative complication risk
Outline your anaesthetic plan for a pancreaticoduodenectomy (Whipple) in a patient with obstructive jaundice.

Major upper abdominal surgery: long duration, large fluid shifts, bleeding risk, and high postoperative morbidity.

  • Pre-op
    • Assess for cholangitis, correct INR with vitamin K, crossmatch, evaluate cardiopulmonary reserve and frailty
    • Discuss postoperative critical care, analgesia strategy, and transfusion plan
  • Intra-op
    • A-line, large-bore IVs, consider CVC, active warming, serial ABGs, urine output monitoring
    • Goal-directed fluids, early noradrenaline for vasoplegia, blood products guided by labs/viscoelastic testing
    • Analgesia: epidural if coagulation acceptable and haemodynamics allow, otherwise intrathecal opioid/regional blocks + multimodal
  • Post-op
    • Monitor for bleeding, sepsis, AKI, respiratory complications, manage glycaemia and nutrition early
What complications can occur after ERCP and how would they present and be managed peri-operatively?

Common FRCA theme: recognise and escalate early.

  • Post-ERCP pancreatitis
    • Epigastric pain, vomiting, raised amylase/lipase, can progress to SIRS/organ failure
    • Management: fluids, analgesia, antiemetics, oxygen, critical care if severe
  • Bleeding
    • Haematemesis/melaena, hypotension, drop in Hb, higher risk with coagulopathy/anticoagulants
    • Management: resuscitation, correct coagulopathy, endoscopic haemostasis ± IR/surgery
  • Perforation
    • Severe pain, tachycardia, surgical emphysema, sepsis, imaging confirms
    • Management: antibiotics, NBM, surgical/IR input, may require laparotomy
  • Cholangitis/bacteraemia
    • Fever, rigors, hypotension, treat as sepsis with antibiotics and ensure adequate drainage
In a jaundiced patient, how might you adjust your choice/dose of anaesthetic drugs?

Answer should mention: titration, protein binding, hepatic clearance, and context (sepsis vs stable).

  • General approach
    • Use lower initial doses if vasodilated/septic, incremental dosing with close haemodynamic monitoring
    • Be cautious with highly protein-bound drugs if hypoalbuminaemic (greater free fraction)
  • Opioids and sedatives
    • Prefer short-acting, titratable agents, avoid excessive long-acting sedatives, consider delirium risk
  • Neuromuscular blockers
    • Use quantitative monitoring, choose agents with predictable clearance where possible, ensure full reversal
When would you avoid an epidural in obstructive jaundice and what alternatives could you offer for upper abdominal surgery?

Key issues: coagulopathy and haemodynamic instability, provide realistic alternatives.

  • Avoid/consider contraindications
    • Raised INR/low platelets or uncertain correction, ongoing sepsis, anticipated profound vasodilation/vasopressor dependence
    • Patient refusal, spinal pathology, or inability to safely manage epidural post-op
  • Alternatives
    • Intrathecal morphine (if coagulation acceptable) + multimodal analgesia
    • Subcostal TAP/rectus sheath blocks, wound catheters, systemic adjuncts (ketamine, lidocaine per policy)
Describe the physiological effects of obstructive jaundice relevant to anaesthesia and critical care.

A high-yield answer is system-based: CVS, renal, coagulation, infection, CNS, pharmacology.

  • Cardiovascular
    • Endotoxaemia/inflammation → vasodilation, increased sensitivity to anaesthetic-induced hypotension
  • Renal
    • Hypoperfusion + inflammatory injury, increased risk with sepsis and nephrotoxins
  • Haematology/coagulation
    • Vitamin K deficiency → prolonged PT/INR, thrombocytopenia possible
  • Infection
    • Ascending infection, ERCP/surgery can precipitate sepsis
  • Pharmacology
    • Altered hepatic excretion/uptake, increased free drug fraction, prolonged effects—titrate and monitor
  • CNS/metabolic
    • Delirium risk, fat-soluble vitamin deficiency, impaired wound healing
A patient with obstructive jaundice is listed for laparotomy. How would you assess and optimise them pre-operatively?

Use a structured pre-op approach: identify cause/urgency, detect sepsis and organ dysfunction, correct reversible problems, plan level of care.

  • Assess severity and urgency
    • Look for fever, hypotension, confusion, review imaging for level of obstruction and need for drainage
  • Investigations
    • Crossmatch, consider ABG/lactate if septic, ECG ± echo/CPET if major surgery and time allows
  • Optimisation
    • Treat sepsis, IV fluids, early vasopressors if required, consider ICU
    • Correct INR with vitamin K, manage anticoagulants, plan blood products if urgent
    • Address renal risk: avoid nephrotoxins, maintain perfusion, correct electrolytes, nutrition support
  • Planning
    • Discuss epidural vs alternatives based on coagulation and haemodynamics, plan invasive monitoring and HDU/ICU bed
Discuss the anaesthetic management of a septic patient with obstructive jaundice requiring emergency biliary drainage.

This is essentially anaesthesia for sepsis + source control, with added coagulopathy/AKI/aspiration considerations.

  • Before theatre
    • Oxygen, cultures, antibiotics, fluids, lactate, start noradrenaline early if shock persists
    • Correct coagulopathy where possible, ensure blood availability
  • Induction
    • A-line before induction if unstable, cautious dosing, vasopressor boluses and infusion ready
  • Intra-op
    • Maintain MAP with noradrenaline ± inotrope if myocardial depression, careful fluid strategy
    • Monitor urine output, ABG/lactate, temperature control, glycaemic control
  • Post-op
    • Ventilation/vasopressors may be required, ongoing antibiotics and organ support, monitor for DIC/AKI

0 comments